Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227532 · ClinicalTrials.gov registry record · NA
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
A NA study of Atrial Fibrillation, sponsored by Biosense Webster.
- Recruiting
- Registry status
- NA
- Development phase
- 276
- Enrollment target
- 7
- Study locations
NCT07227532 is a NA study of Atrial Fibrillation that is actively recruiting participants, run by Biosense Webster. The registered enrollment target is 276 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT07227532, a NA study of Atrial Fibrillation, is actively recruiting participants, sponsored by Biosense Webster.
- RECRUITING
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
Conditions Studied
Interventions
- DEVICE Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator
Study Locations (7)
California
- OC Memorial - Fountain Valley
- Community Memorial Hospital - Ventura
Florida
- Orlando Health Heart and Vascular Institute - Orlando
Kansas
- The Kansas City Heart Rhythm Institute - Overland Park
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Virginia
- Winchester Medical Center - Winchester
Wisconsin
- Mercy Hospital - Janesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2025-10-21 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07227532
The ClinicalTrials.gov registry entry for NCT07227532 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower). The listed sponsor is Biosense Webster, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator is the first listed.
NCT07227532 reports 7 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT07227532 about?
NCT07227532 is a clinical study titled "A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System". The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
What is the current status of trial NCT07227532?
This trial is currently recruiting. It is a NA study. The enrollment target is 276 participants. The study started on 2025-10-21. Estimated completion is 2030-12-31.
What conditions does trial NCT07227532 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT07227532?
The interventions under investigation include: Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator (DEVICE).
Who is sponsoring clinical trial NCT07227532?
This trial is sponsored by Biosense Webster, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227532 being conducted?
This trial has 7 study locations across California, Florida, Kansas, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.